SteelPeak Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,615
| Closed | -$2.29M | – | 555 |
|
2025
Q1 | $2.29M | Buy |
3,615
+792
| +28% | +$502K | 0.1% | 161 |
|
2024
Q4 | $2.01M | Buy |
2,823
+1,715
| +155% | +$1.22M | 0.08% | 168 |
|
2024
Q3 | $1.16M | Buy |
1,108
+16
| +1% | +$16.8K | 0.05% | 206 |
|
2024
Q2 | $1.15M | Buy |
1,092
+692
| +173% | +$727K | 0.05% | 205 |
|
2024
Q1 | $385K | Buy |
+400
| New | +$385K | 0.02% | 313 |
|
2023
Q1 | – | Sell |
-7,346
| Closed | -$5.3M | – | 405 |
|
2022
Q4 | $5.3M | Buy |
+7,346
| New | +$5.3M | 0.39% | 60 |
|
2022
Q3 | – | Sell |
-2,442
| Closed | -$1.44M | – | 418 |
|
2022
Q2 | $1.44M | Buy |
+2,442
| New | +$1.44M | 0.1% | 137 |
|
2021
Q4 | – | Sell |
-501
| Closed | -$303K | – | 424 |
|
2021
Q3 | $303K | Sell |
501
-999
| -67% | -$604K | 0.02% | 318 |
|
2021
Q2 | $838K | Buy |
+1,500
| New | +$838K | 0.06% | 189 |
|